References
- Greenwood D. Sixty years on: antimicrobial drug resistance comes of age. Lancet 346 Suppl 1995; 1: S1
- Neu H. Emerging trends in antimicrobial resistance in surgical infections. Eur J Surg 1994; 573: 7–18
- Shlaes D M, Binczewski B, Rice L B. Emerging antimicrobial resistance and the immunocompromised host. Clin Infect Dis 17 Suppl 1993; 2: 527–36
- Hawkey P M. Resistant bacteria in the normal human flora. J Antimicrob Chemother 1986; 18: 133–9
- Quintiliani R, Courvalin P. Mechanisms of resistance to antimicrobial agents. Manual of clinical microbiolog, P R Murray. ASM Press., Washington DC 1995; 1308–26
- Tanaka M, Otsuki M, Une T, Nishino T. In vitro and in vivo activity of DR-3355, an optically active isomer of ofloxacin. J Antimicrob Chemother 1990; 26: 659–66
- Heimdahl A, Nord C E. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man Scand. J Infect Dis 1979; 11: 233–42
- Monk J P, Campoli-Richards D M. Ofloxacin: A review of it antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1987; 33: 346–91
- Edlund C, Kager L, Malmborg A S, Sjötedt S, Nord C E. Effect of ofloxacin on oral and gastrointestinal microflora in. patients undergoing gastric surgery. Eur J Clin Microbiol Infect Dis 1988; 7: 135–43
- Edlund C, Nord C E. Ecological impact of antimicrobial agents on human intestinal microflora. Alpe Adria Microbiol 1993; 3: 37–64
- Edlund C, Lindqvist L, Nord C E. Norfloxacin binds to human fecal material. Antimicrob Agents Chemother 1988; 32: 1869–74
- van der Waaij D. The ecology of the human intestine and itsconsequences for overgrowth by pathogens such as Clostridium difficile. Ann Rev Microbiol 1989; 43: 69–87
- Vollaard E J, Clasener H AL. Colonization resistance. Antimicrob Agents Chemother 1994; 38: 409–14
- Amyes S GB, Gemmell C G. Review article: Antibiotic resistance in bacteria. J Med Microbiol 1992; 36: 4–29